Literature DB >> 18295795

Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.

Michael Ellison1, Zhi-Ping Feng, Anthony J Park, Xuecheng Zhang, Baldomero M Olivera, J Michael McIntosh, Raymond S Norton.   

Abstract

Alpha-conotoxins are small disulfide-constrained peptides from cone snails that act as antagonists at specific subtypes of nicotinic acetylcholine receptors (nAChRs). The 13-residue peptide alpha-conotoxin RgIA (alpha-RgIA) is a member of the alpha-4,3 family of alpha-conotoxins and selectively blocks the alpha9alpha10 nAChR subtype, in contrast to another well-characterized member of this family, alpha-conotoxin ImI (alpha-ImI), which is a potent inhibitor of the alpha7 and alpha3beta2 nAChR subtypes. In this study, we have altered side chains in both the four-residue and the three-residue loops of alpha-RgIA, and have modified its C-terminus. The effects of these changes on activity against alpha9alpha10 and alpha7 nAChRs were measured; the solution structures of alpha-RgIA and its Y10W, D5E, and P6V analogues were determined from NMR data; and resonance assignments were made for alpha-RgIA [R9A]. The structures for alpha-RgIA and its three analogues were well defined, except at the chain termini. Comparison of these structures with reported structures of alpha-ImI reveals a common two-loop backbone architecture within the alpha-4,3 family, but with variations in side-chain solvent accessibility and orientation. Asp5, Pro6, and Arg7 in loop 1 are critical for blockade of both the alpha9alpha10 and the alpha7 subtypes. In loop 2, alpha-RgIA [Y10W] had activity near that of wild-type alpha-RgIA, with high potency for alpha9alpha10 and low potency for alpha7, and had a structure similar to that of wild type. By contrast, Arg9 in loop 2 is critical for specific binding to the alpha9alpha10 subtype, probably because it is larger and more solvent accessible than Ala9 in alpha-ImI. Our findings contribute to a better understanding of the molecular basis for antagonism of the alpha9alpha10 nAChR subtype, which is a target for the development of analgesics for the treatment of chronic neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295795      PMCID: PMC2376044          DOI: 10.1016/j.jmb.2008.01.082

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  40 in total

1.  Pairwise interactions between neuronal alpha7 acetylcholine receptors and alpha-conotoxin ImI.

Authors:  P A Quiram; J J Jones; S M Sine
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

2.  A glia-derived acetylcholine-binding protein that modulates synaptic transmission.

Authors:  A B Smit; N I Syed; D Schaap; J van Minnen; J Klumperman; K S Kits; H Lodder; R C van der Schors; R van Elk; B Sorgedrager; K Brejc; T K Sixma; W P Geraerts
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  The Xplor-NIH NMR molecular structure determination package.

Authors:  Charles D Schwieters; John J Kuszewski; Nico Tjandra; G Marius Clore
Journal:  J Magn Reson       Date:  2003-01       Impact factor: 2.229

4.  Mimotopes of apical membrane antigen 1: Structures of phage-derived peptides recognized by the inhibitory monoclonal antibody 4G2dc1 and design of a more active analogue.

Authors:  Jennifer K Sabo; David W Keizer; Zhi-Ping Feng; Joanne L Casey; Kathy Parisi; Andrew M Coley; Michael Foley; Raymond S Norton
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

5.  MOLMOL: a program for display and analysis of macromolecular structures.

Authors:  R Koradi; M Billeter; K Wüthrich
Journal:  J Mol Graph       Date:  1996-02

6.  The program XEASY for computer-supported NMR spectral analysis of biological macromolecules.

Authors:  C Bartels; T H Xia; M Billeter; P Güntert; K Wüthrich
Journal:  J Biomol NMR       Date:  1995-07       Impact factor: 2.835

7.  Single-residue alteration in alpha-conotoxin PnIA switches its nAChR subtype selectivity.

Authors:  S Luo; T A Nguyen; G E Cartier; B M Olivera; D Yoshikami; J M McIntosh
Journal:  Biochemistry       Date:  1999-11-02       Impact factor: 3.162

8.  Alpha-conotoxins ImI and ImII. Similar alpha 7 nicotinic receptor antagonists act at different sites.

Authors:  Michael Ellison; J Michael McIntosh; Baldomero M Olivera
Journal:  J Biol Chem       Date:  2002-10-15       Impact factor: 5.157

9.  Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes.

Authors:  Huashan Peng; Robert L Ferris; Tonya Matthews; Hakim Hiel; Andres Lopez-Albaitero; Lawrence R Lustig
Journal:  Life Sci       Date:  2004-12-03       Impact factor: 5.037

10.  'Random coil' 1H chemical shifts obtained as a function of temperature and trifluoroethanol concentration for the peptide series GGXGG.

Authors:  G Merutka; H J Dyson; P E Wright
Journal:  J Biomol NMR       Date:  1995-01       Impact factor: 2.835

View more
  39 in total

1.  Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.

Authors:  Peter N Huynh; Peta J Harvey; Joanna Gajewiak; David J Craik; J Michael McIntosh
Journal:  Biochem Pharmacol       Date:  2020-06-25       Impact factor: 5.858

2.  Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.

Authors:  Layla Azam; J Michael McIntosh
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

Review 3.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors:  Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

4.  Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.

Authors:  Sulan Luo; Dongting Zhangsun; Peta J Harvey; Quentin Kaas; Yong Wu; Xiaopeng Zhu; Yuanyan Hu; Xiaodan Li; Victor I Tsetlin; Sean Christensen; Haylie K Romero; Melissa McIntyre; Cheryl Dowell; James C Baxter; Keith S Elmslie; David J Craik; J Michael McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

5.  Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.

Authors:  Layla Azam; Athanasios Papakyriakou; Marios Zouridakis; Petros Giastas; Socrates J Tzartos; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2015-03-04       Impact factor: 4.436

6.  Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion.

Authors:  Keith K Khoo; Zhi-Ping Feng; Brian J Smith; Min-Min Zhang; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj; Raymond S Norton
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

7.  Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.

Authors:  Reena Halai; Richard J Clark; Simon T Nevin; Jonas E Jensen; David J Adams; David J Craik
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

Review 8.  Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.

Authors:  Layla Azam; J Michael McIntosh
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

Review 9.  Integrating the discovery pipeline for novel compounds targeting ion channels.

Authors:  Grzegorz Bulaj
Journal:  Curr Opin Chem Biol       Date:  2008-08-03       Impact factor: 8.822

10.  Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.

Authors:  Dinesh C Indurthi; Elena Pera; Hye-Lim Kim; Cindy Chu; Malcolm D McLeod; J Michael McIntosh; Nathan L Absalom; Mary Chebib
Journal:  Biochem Pharmacol       Date:  2014-02-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.